Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Australia, from 1982 to 2019: Based on site, grade, and region

Michael, M; Thursfield, V; te Marvelde, L; Kong, G; Hicks, RJ

Author(s): Michael, M; Thursfield, V; te Marvelde, L; Kong, G; Hicks, RJ;
Details: Publication Year 2022-10,Volume 18,Issue #5,Page e306-e317
Journal Title: Asia-Pacific Journal of Clinical Oncology
Publication Type: Research article
Abstract: AIMS: Neuroendorcine neoplasms (NENs) are rare tumors characterised by variable biology and delayed diagnosis. Several population studies have reported a marked increased incidence over time. The objectives of this analysis were to describe within Victoria (the second largest Australian state, 6.4 Million) the trends for NENs incidence/survival over nearly 38 years (1982-2019), and regional differences in survival. METHODS: All NEN cases were identified from the Victorian Cancer Registry over four time periods: 1982-1989, 1990-1999, 2000-2009, and 2010-2019. Data collected included primary tumor site, histological grade, gender, overall survival (OS), and place of residence. Incidence data were analyzed with the generation of annual standardized rates (ASR). OS was assessed for the entire cohort and between geographical regions. RESULTS: The overall NEN population (1982-2019) included 8,106 patients: over 60% grade 1/2 NENs, especially small bowel and colorectal. The number of new diagnoses increased over three-fold over time for the overall cohort and by tumoral categories. The ASR increased similarly, especially pancreatic NENs (4.3-fold) and differed between genders. The 5-year OS rates and median OS increased over time for the overall cohort: from 52% to 67% (p < 0.001). OS was greater for NEN patients residing in major cities relative to regional/remote areas (p = 0.01). CONCLUSION: This population-wide analysis with over 38 years of data has confirmed the international trends of the increased incidence, prevalence, and OS of NEN patients regardless of primary site or histological grade. The analysis also observed a difference in survival outcome in rural/remote versus urban areas.
Publisher: Wiley
Keywords: Female; Humans; Incidence; Male; *Neuroendocrine Tumors/pathology; *Pancreatic Neoplasms/pathology; Prevalence; Victoria/epidemiology; neuroendocrine; population; survival
Department(s): Medical Oncology; Cancer Imaging
PubMed ID: 34821050
Publisher's Version: https://doi.org/10.1111/ajco.13671
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2025-01-31 07:02:49

Last Modified: 2025-01-31 07:03:46